Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Essen Biotech
Dana-Farber Cancer Institute
University of California, Davis
AgonOx, Inc.
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
H. Lee Moffitt Cancer Center and Research Institute
Hadassah Medical Organization
Vastra Gotaland Region
Vastra Gotaland Region
H. Lee Moffitt Cancer Center and Research Institute
Medicenna Therapeutics, Inc.
University of California, San Diego
Case Comprehensive Cancer Center